Skip to main content
386 search results for:

Medications 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 07-11-2022 | Giant cell arteritis | News | Article

    Studies evaluate medications, biomarkers linked to GCA risk

    Findings from two studies published in Rheumatology suggest that angiotensin receptor blocker use may be associated with an increased risk for developing giant cell arteritis, and that interferon-γ may warrant further investigation as a risk biomarker.

  2. 28-04-2021 | BSR 2021 | Conference coverage | Article

    Suboptimal prescribing of osteoporosis medications in people with polymyalgia rheumatica

    Less than half of patients with polymyalgia rheumatica are prescribed medications for osteoporosis, despite clinical guidelines recommending bone protection for those on long-term glucocorticoid treatment, research suggests.

  3. Heart Matters: Integrate CV Risk, Medications & Physical Activity in RA

    Georgia World Congress Center, Atlanta, USA Moderators:  Diane Horowitz, USA; Monica Richey, USA Cardiovascular Risk Profiles in RA & Physical Activity's Influence on CV Risk  Mary Christenson, USA Common RA Medications: Balancing the Cardiovascular Risks & Benefits  Leticia Shea, USA

  4. 02-01-2019 | Osteoarthritis | Highlight | Teaser
    medwireNews top story

    Long-term impact unclear for knee OA medications

    Findings from a systematic review and network meta-analysis published in JAMA indicate that it is not clear whether pharmacologic treatments offer long-term benefits for patients with knee osteoarthritis.

  5. 21-12-2018 | Osteoarthritis | News | Article

    Long-term impact unclear for knee OA medications

    The team concludes that “[l]arger randomized clinical trials are needed to resolve the uncertainty around the long-term efficacy of medications for knee osteoarthritis.”

  6. 22-02-2018 | Rheumatoid arthritis | Article

    Real-world treatment patterns for golimumab and concomitant medications in Japanese rheumatoid arthritis patients

    The aim of this study was to investigate real-world treatment patterns for use of golimumab and concomitant medications in Japanese patients with

  7. 06-02-2018 | Osteoporosis | Review | Article

    Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: A systematic review

    Anagnostis P et al. Endocrine 2018; Advance online publication. doi: 10.1007/s12020-018-1548-x

  8. 02-04-2018 | Quality of life | Review | Article

    How do patients with systemic autoimmune rheumatic disease perceive the use of their medications: A systematic review and thematic synthesis of qualitative research

    Haag H et al. BMC Rheumatol 2018; 2: 9. doi: 10.1186/s41927-018-0017-8

  9. 23-11-2022 | ACR 2022 | Conference coverage | Article

    LOUiSSe study shows remibrutinib efficacy in Sjögren’s syndrome

    Remibrutinib, an oral Bruton’s tyrosine kinase inhibitor, has shown potential for the treatment of Sjögren's syndrome in a phase 2 study.

  10. 18-11-2022 | ACR 2022 | Conference coverage | Article

    A Great Debate: To treat or not to treat in pre-RA?

    Recognizing the potential impact of treating or not treating pre-RA In her closing comments, Pope invited the audience to consider the impact of treating and following up five times more patients with no inflammatory arthritis and the increased burden this would have on rheumatologic care as well as a potential increase in the use of imaging facilities and medications that may not even stop or prevent RA.

  11. 21-11-2022 | ACR 2022 | Conference coverage | Article

    Abortion restrictions impede methotrexate access for some rheumatology patients

    The presenter concluded: “Because most issues experienced were delays by pharmacies in seeking to confirm the purpose of the prescription, we recommend that healthcare providers prescribing abortifacient medications include the patient’s rheumatic diagnosis on the prescription to reduce or avoid delays.” medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ACR Convergence 2022; Philadelphia, Pennsylvania, USA: November 10–14

  12. 16-11-2022 | ACR 2022 | Conference coverage | Article

    PD-1 receptor agonist may represent a novel treatment for patients with RA

    Peresolimab, a PD-1 receptor agonist, may represent a promising approach to treating rheumatoid arthritis, with an “encouraging” safety profile, suggests research reported at the ACR Convergence 2022 in Philadelphia, Pennsylvania, USA.

  13. 14-11-2022 | ACR 2022 | Conference coverage | Article

    Phase 3 trial supports add-on telitacicept for SLE

    Addition of the recombinant fusion protein telitacicept to standard care may reduce disease activity and is well tolerated in people with systemic lupus erythematosus, research suggests.

  14. 10-11-2022 | Systemic lupus erythematosus | News | Article

    Achieving LLDAS tied to reduced mortality risk in SLE

    Writing in an accompanying comment, Daniel Wallace (Cedars-Sinai Medical Center, Los Angeles, California, USA) says that although the results are “important and relevant,” the study had several caveats, including a short duration of follow-up and limited generalizability given that only 3.6% of patients were on biologic medications.

  15. 01-11-2022 | Systemic lupus erythematosus | News | Article

    Dapagliflozin may warrant further investigation for SLE

    Dapagliflozin deserves further study as an add-on therapy for reducing renal and cardiovascular risk in patients with systemic lupus erythematosus, suggest preliminary trial findings.

  16. 18-10-2022 | Psoriatic arthritis | News | Article

    Support for JAK inhibitors as ‘drug of choice’ for patients with PsA and significant joint disease

    JAK inhibitors show promise for the treatment of moderate-to-severe psoriasis and psoriatic arthritis, finds a systematic review and meta-analysis of more than 6000 patients.

  17. 06-10-2022 | Gout | News | Article
    News in brief

    SGLT2 inhibitors linked to lower gout risk than DPP-4 inhibitors

    After propensity score matching, the 16,144 people treated with SGLT2 inhibitors had a significantly lower risk for developing gout than the same number of matched individuals on DPP-4 inhibitors, with a hazard ratio (HR) of 0.49 after adjustment for factors including comorbidities, medications, and glycemic control.

  18. 23-09-2022 | Axial spondyloarthritis | News | Article

    Successful retreatment of axSpA flare feasible following ixekizumab withdrawal

    “Expected or otherwise, patients sometimes pause or stop biologic medications, and clinicians and patients may have concerns about recapturing efficacy when drugs are restarted,” explain Robert Landewé, from Amsterdam Rheumatology Center in the Netherlands, and co-researchers.

  19. 12-09-2022 | Methotrexate | News | Article

    Methotrexate side effects more common in PsA than RA

    Ogdie et al note that the patients with PsA had a higher BMI, on average, than those with RA, and were also more likely to have fibromyalgia and depression, “which may all contribute to the symptom profile and side effects to medications.”

  20. 13-07-2022 | Surgery | News | Article
    guidelinesWatch

    US guidelines issued for the use of rheumatology drugs around the time of hip, knee replacement

    The American College of Rheumatology and the American Association of Hip and Knee Surgeons have issued updated recommendations to guide perioperative use of antirheumatic medications among people with rheumatic diseases undergoing total hip or knee arthroplasty.

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.